Is Filament Health Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Filament Health Corp (FH.NE) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Filament Health Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Filament Health Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Filament Health Corp?

Muslim investors may consider investing in Filament Health Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Filament Health Corp classified as HALAL?

Musaffa determines the Shariah status of Filament Health Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Filament Health Corp updated?

The Shariah compliance status of Filament Health Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Filament Health Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Filament Health Corp?

You can check the latest Shariah compliance status of Filament Health Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

FH.NE Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 16, 2025

Report Source: 2025 1st Quarter Report

Filament Health Corp. Stock Analysis FH.NE

Canada N/A Nano Cap Report: Q1, 2025

Filament Health Corp. is a clinical-stage natural psychedelic drug development company, which engages in the discovery and development of natural psychedelic pharmaceuticals. The company is headquartered in Burnaby, British Columbia. The company went IPO on 2021-06-24. The Company’s platform of intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of Psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The firm's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.

Key Statistics of Filament Health Corp (FH.NE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.01CAD0.02

Today's Open

CAD0.01

Volume

929.48K

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.04

Market Cap

2.62M

Avg. Volume

302.48K

Dividend Yield

Financial Metrics & Statements of Filament Health Corp (FH.NE)

FAQ's for Filament Health Corp (FH.NE)

According to Musaffa’s Shariah screening methodology, Filament Health Corp (FH.NE) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.